Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,256Revenue (TTM) $M1,507Net Margin (%)60.0Altman Z-Score10.9
Enterprise Value $M4,286EPS (TTM) $18.1Operating Margin %71.5Piotroski F-Score7
P/E(ttm)6.5Beneish M-Score-1.8Pre-tax Margin (%)94.6Higher ROA y-yY
Price/Book3.210-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsN
Price/Sales3.95-y EBITDA Growth Rate %37.0Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow17.0y-y EBITDA Growth Rate %361ROA % (ttm)44.5Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)65.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.6ROIC % (ttm)109Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2016-03-31 Add0.04%$108.47 - $156.61
($127.11)
$ 117.78-7%Add 10.43%362,565
UTHRGeorge Soros 2016-03-31 Sold Out -0.01%$108.47 - $156.61
($127.11)
$ 117.78-7%Sold Out0
UTHRDavid Dreman 2016-03-31 Buy $108.47 - $156.61
($127.11)
$ 117.78-7%New holding125
UTHRKen Fisher 2016-03-31 Reduce$108.47 - $156.61
($127.11)
$ 117.78-7%Reduce -1.43%3,092
UTHRFirst Eagle Investment 2015-12-31 Sold Out -0.18%$119.57 - $160.91
($146.21)
$ 117.78-19%Sold Out0
UTHRJoel Greenblatt 2015-12-31 Add0.05%$119.57 - $160.91
($146.21)
$ 117.78-19%Add 9.00%328,310
UTHRGeorge Soros 2015-12-31 Buy 0.01%$119.57 - $160.91
($146.21)
$ 117.78-19%New holding4,400
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 117.78-19%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 117.78-27%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 117.78-27%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 117.78-27%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 117.78-34%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 117.78-34%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 117.78-23%Reduce -9.91%291,077
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 117.78-23%New holding2,450
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 117.78-23%Add 3.44%372,580
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 117.78-9%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 117.7814%Reduce -55.36%288,401
UTHRFirst Eagle Investment 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 117.7814%New holding262,080
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 117.7822%Add 104.14%646,066
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & Co-CEO 2016-05-19Sell5,546$110.756.35view
DWEK RAYMONDDirector 2016-05-12Sell3,000$1107.07view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-05-12Sell5,547$109.028.04view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-05-05Sell5,546$107.799.27view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-28Sell5,547$106.8110.27view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-21Sell5,546$115.741.76view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-14Sell5,547$114.323.03view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-04-07Sell5,546$113.313.94view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-24Sell5,546$110.86.3view
ROTHBLATT MARTINE AChairman & Co-CEO 2016-03-17Sell5,547$118.22-0.37view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
United Therapeutics Is a Value Investor's Biotech Dream Apr 28 2016 
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
John Hussman's Third Quarter Top 5 Nov 07 2013 
Vanguard Health Care Fund Selling Update Oct 30 2013 
Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 

More From Other Websites
United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : May 24,... May 24 2016
ETF’s with exposure to United Therapeutics Corp. : May 16, 2016 May 16 2016
Aging Is So Yesterday May 16 2016
SteadyMed Provides Corporate Update and Reports First Quarter 2016 Financial Results May 11 2016
United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q1, 2016 By the Numbers May 10 2016
UNITED THERAPEUTICS CORP Financials May 03 2016
United (UTHR) Stock Declines Despite Q1 Earnings Beat Apr 29 2016
United Therapeutics downgraded by Ladenburg Thalmann Apr 29 2016
The 52-Week Low Club for Thursday Apr 28 2016
Edited Transcript of UTHR earnings conference call or presentation 28-Apr-16 1:00pm GMT Apr 28 2016
Roger Jeffs out in executive shakeup at drugmaker United Therapeutics Apr 28 2016
United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today Apr 28 2016
Q1 2016 United Therapeutics Corp Earnings Release - Before Market Open Apr 28 2016
UNITED THERAPEUTICS CORP Files SEC form 8-K, Change in Directors or Principal Officers Apr 28 2016
United Therapeutics Corporation Announces Executive Leadership Changes Apr 28 2016
United Therapeutics Corporation Reports First Quarter 2016 Financial Results Apr 28 2016
United Therapeutics beats 1Q profit forecasts Apr 28 2016
United Therapeutics beats 1Q profit forecasts Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)